Abstract: An amidinonaphthyl derivative represented by the following general formula (I) which has coagulation factor X inhibiting action and is useful as an anti-thrombus agent and the like, a salt thereof, an intermediate thereof and a pharmaceutical composition which comprises the amidinonaphthyl derivative. An amidinonaphthyl derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof. ##STR1## (symbols in the formula have the following meanings; R.sup.1 : a hydrogen atom or a group represented by the formula --A--W--R.sup.4,A: a group represented by the formula ##STR2## a group represented by the formula ##STR3## or a group represented by the formula --SO.sub.2 --, X: an oxygen atom or a sulfur atom, W: a single bond or a group represented by the formula --NR.sup.5 --, R.sup.4 : a hydroxyl group, a lower alkoxy group, etc., R.sup.5 : a hydrogen atom, a carbamoyl group, a lower alkoxycarbonyl group, etc., R.sup.2 : a lower alkyl group, R.sup.

Abstract: An ester compound, for example, carbonic acid ester or succinic acid ester, is produced by catalytically reacting, in gas phase, carbon monoxide with a nitrous acid ester and optionally an olefin in the presence of a catalyst and in the presence of a chlorine-containing substance, bringing the reaction product-containing mixed gas into contact with a solid catalyst such as activated carbon or inorganic oxide to reduce the content of the chlorine-containing substance, cool-condensing the resultant mixed gas, and collecting the target ester compound from the condensed liquid.

Abstract: This invention provides compositions for fair-skin containing the phosphorylated polysaccharides produced by lactic acid bacteria as an effective ingredient. The phosphorylated polysaccharides are expressed, for example, by the following formula and contained in the compositions for fair-skin at concentrations of 0.01-20 weight % and are used such as creams, emulsions and toilet lotions.The compositions for fair-skin exhibit fair-skin effect by inhibiting activities to melanoma proliferation and melanin formation. ##STR1## (wherein, Glc, Gal and Rha represent glucose, galactose and rhamnose residues, respectively. Numerals shown by other than subscript represent the respective binding sites and n represents the degree of polymerization of 1,000-5,000).

Abstract: A hollow fiber blood purifying membrane which is a hollow fiber membrane substantially composed of cellulose acetate, has a substantially non-oriented distribution of cellulose acetate polymer particles on the inner surface of the hollow fibers, has a dense layer with a thickness in the range of 30-1000 nm on both the inner and outer surface of the hollow fibers and a porous structure which is substantially uniform at the membrane wall between the two dense layers, and has an in vitro ultrafiltration rate (UFR) of 10 to 50 ml/m.sup.2 .multidot.mmHg.multidot.hr and a (in vivo UFR)/(in vitro UFR) ratio of at least 0.3, a blood plasma albumin permeation blockage of at least 90%, and an in vivo .beta..sub.2 -microglobulin (.beta..sub.2 -MG) sieving coefficient of at least 0.4, as well as a process for its production.

Abstract: It is an object of the present invention to reduce the abrasion at a pressure receiving portion of the cylinder block, without increasing the manufacturing cost, even when the outer rings of a bearing are jointly rotated and eccentrically fluctuated. The cylinder blocks are made of aluminum alloy comprising, by weight, 1.5 to 3.5% of Cu, 13 to 16% of Si, 0.5% or less of Mg, 1.0% or less of Zn, 1.0% or less of Fe and the remainder of Al. The matrix, except for primary Si crystal, is relatively soft. Primary Si crystals which each independently project from the pressure receiving portions tend to be pushed into the base material by the outer rings of the thrust bearings, so that the levels of primary Si crystals are easily made to be approximately uniform.

Abstract: A new immunotherapy to cancer patients is provided. In the therapy, lymphocytes collected from a patient by leukopheresis are treated with interferon-.alpha. in vitro for a short period of term and then returned to the patient intravenously. According to the therapy, reduction in sensitivity of tumor cells to natural killer-cell lysis due to administration of interferon-.alpha. is eliminated, the activities of NK cell and 2-5AS and interferon-producing capacity can be enhanced, a large amount of lymphocytes can be activated directly in vitro with the dose of optimally adjusted to the patient, none of side effects are found, and any other potentiators and comodulaators, which may not be allowed to use in vivo, can be added to the lymphocytes and removed therefrom before returning to the patient.

Abstract: A reciprocating piston type compressor having a cylinder block unit closed, at at least one of the axial ends thereof, by a housing having a central suction chamber and a discharge chamber arranged around the suction chamber hermetically isolated by a separation wall integral with the housing, a valve plate interposed between the end of the cylinder block unit and the housing and having suction and discharge ports, suction passageways formed in the cylinder block unit to have fluid communication with the suction chamber via openings thereof, a plurality of pressing ribs axially integrally extending from an inner face of the housing toward the valve plate so as to apply a higher pressure to the valve plate at positions of the valve plate between respective two neighboring openings of the suction passageways in cooperation with the separating wall to prevent deformation of the valve plate due to the high pressure of the refrigerant in the respective cylinder bores whereby the hermetic seal between the valve pla

Abstract: The viscous type heat generator includes a housing having a heating chamber and a heat radiating chamber. A rotor is rotatably arranged in the heating chamber so that a viscous fluid is subjected to a shearing action to generate heat. The rotor is fitted on a drive shaft in such a manner that the rotor can not rotate but can move axially relative to the drive shaft. The front and rear end surfaces of the rotor have wedge effect producing means for correcting an axial offset of the rotor in the heating chamber by the wedge effect caused by the pressure of viscous fluid while the rotor is rotating. This wedge effect producing means comprises at least three inclined recesses extending in the circumferential direction, the bottoms of which become gradually shallower in the direction opposite to the rotational direction of the rotor. The inclined recesses are arranged at circumferentially regular intervals and at radially equal positions from the center of the rotor.

Abstract: A climate controller for an automobile, comprising a compressor and a receiver arranged in an engine compartment of the automobile, a condenser located at an outside-air inlet of the engine compartment, an expansion member and an evaporator disposed in a passenger compartment of the automobile, and a closed-loop refrigerant passage connecting the compressor, the condenser, the receiver, the expansion member and the evaporator in sequence for circulating a refrigerant through these components to establish a refrigerating cycle. The climate controller further includes a valve arranged in a part of the closed-loop refrigerant passage extending from the evaporator through the compressor to the condenser. The valve is actuated to intersect a communication of the refrigerant through the part of the passage when an operation affecting temperature of both the compressor and the condenser becomes ineffective, and to allow the communication when the operation becomes effective.

Abstract: A 5-HT.sub.3 receptor against containing a thiazole derivative as the effective ingredient is provided and is represented by the Formula (I): ##STR1## wherein the A ring is substituted or unsubstituted and represents a benzene or a heterocyclic ring with one or two heteroatoms;one of L.sub.1 or L.sub.

Abstract: A quinuclidine derivative represented by the following general formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, which has strong squalene synthase inhibiting activity and is useful as a cholesterol lowering agent without causing side effects. ##STR1## (Symbols in the formula represent the following meanings; R.sub.1 : a hydrogen atom, a halogen atom or a lower alkyl group,R.sub.2 : a hydrogen atom, a hydroxyl group or a lower alkoxy group,. . : a single bond or a double bond, with the proviso thatR.sub.2 does not exist when . . . is a double bond,X and Y: the same or different from each other and each represents a bond, an oxygen atom (--O--), a carbonyl group (--CO--), a group represented by the formula --S(O).sub.p -- or a group represented by the formula --NR.sub.3 --,p: 0, 1 or 2,R.sub.3 : a hydrogen atom or a lower alkyl group which may have a substituent,A: a saturated or unsaturated lower alkylene group, a group of the formula --(CH.sub.2).sub.m Z(CH.sub.

Abstract: The invention relates to an active ingredient patch in the form of a laminate, the patch comprising a carrier and a matrix of a single polymer and if appropriate another polymer and vitamin E.

Abstract: For controlling physical quantities in industrial plants, and particularly in the crude oil processing industries, the chemical and papermaking industries and gas, power stations and distribution networks, the value of a controlled physical quantity, subjected to perturbations, is kept between two limit values by modifying an action quantity. The action quantity should have small amplitudes in order to stabilize the downstream flows and should evolve so as to anticipate the perturbations. It is determined by performing fuzzy inference on a set of predefined decision rules, on the basis of values of the controlled physical quantity, of a secondary variable connected with the controlled physical quantity and of a context variable obtained from at least one detection variable or from a combination of detection variables representative of the physical quantities at the origin of the perturbations in the controlled physical quantity.

Abstract: A viscous fluid type heat generator including a housing assembly defining a heat generating chamber and an additional chamber communicated through fluid passageway means with the heat generating chamber, these chambers forming a fluid-tight chamber for accommodating a viscous fluid, and a heat receiving chamber for permitting a heat exchanging fluid to circulate therethrough to receive heat from the heat generating chamber. A rotor element is mounted on a drive shaft for rotation together therewith in the heat generating chamber with a gap defined between the inner wall surfaces of the heat generating chamber and the outer faces of the rotor element. The fluid passageway means includes a fluid withdrawing passageway for withdrawing the viscous fluid from the gap into the additional chamber and a fluid supply passageway for supplying the viscous fluid from the additional chamber into the gap.

Abstract: An amount of water is added to a glycol solution to be purified to enable segregation of the resulting mixture into a hydrocarbon phase and a glycol phase. The hydrocarbon phase is separated from the glycol phase and said glycol phase is desalted, e.g. by electrodialysis, to give a desalted and substantially hydrocarbon-free glycol solution which is then concentrated by steam stripping. The method is useful for purifying waste glycol solutions resulting from oil or gas production effluent processing using glycols, and in particular from a gas hydrate inhibition treatment or natural gas dehydration.

Abstract: 1,8-Naphthyridine derivatives represented by the following general formula (I), salts thereof, hydrates thereof and solvates thereof. ##STR1## They have an activity to inhibit type IV phosphodiesterase and are useful as agents for the prevention and treatment of respiratory diseases, inflammatory diseases accompanying organ transplantation, systemic or local arthropathy, proliferative diseases, micturition-related diseases and diseases in which tumor necrosis factor (TNF) and other cytokine (IL-1, IL-6 or the like) are concerned.

Abstract: A blood dialyzer is produced by a process in which a plurality of artificial composite fibers having core portions consisting of a water-insoluble core liquid and surrounded by sheath portions consisting of a fiber-forming polymer are subjected to a removal of almost all of the core liquid; the resultant hollow fibers are bundled; the hollow fiber bundle is packed in a cylindrical case having open end; end portions of spaces left between the hollow fibers peripheries and between the hollow fibers and the inside surface of the cylindrical case are sealed with a bonding material, to fix the hollow fiber bundle to the cylindrical case at the end portions thereof; and the hollow fibers in the cylindrical case are cleaned with a cleaning liquid comprising at least one aliphatic monohydric alcohol having 3 to 8 carbon atoms.

Abstract: A double-headed swash-plate operated reciprocating piston type refrigerant compressor having front and rear cylinder blocks provided with axial cylinder bores for receiving the double-headed pistons reciprocated by a swash plate mounted on an axial drive shaft rotating about an axis of rotation thereof together with the swash plate which is axially and rigidly supported by front and rear thrust bearing assemblies including an elastic unit arranged between the thrust bearing of at least one of the front and rear thrust bearing assemblies and a pressure receiving seat formed in the shoulder portion of the swash plate, the elastic unit providing the swash plate with a axial mechanical support having a rigidity which changes in a stepwise manner in response to a change in a discharge pressure of the refrigerant compressed by the compressor.

Abstract: A diaryl carbonate with a high degree of purity is produced at a high yield by (A) subjecting (a) a diaryl oxalate and a phenol compound or (b) an alkylaryl oxalate to transesterification reaction in one or two stages in the presence of a catalyst to prepare a diaryl oxalate, while removing a by-product from the reaction system; (B) collecting the diaryl oxalate from the resultant reaction product mixture of the step (A); (C) subjecting the diaryl oxalate to a decarbonylation reaction, preferably in the presence of a phosphorous compound-containing catalyst, to convert the diaryl oxalate to a corresponding diaryl carbonate, while removing a reaction by-product comprising carbon monoxide from the reaction system; and (D) collecting the diaryl carbonate from the reaction product mixture of the step (C).

Abstract: This invention relates to methods for substitution of an amino group of a heterocyclic primary amine by a chlorine atom and synthesis of 2-chloro-5-methylthiazole and its derivatives by application thereof.Typically, a heterocyclic primary amine and sodium nitrite are caused to react in the presence of hydrochloric acid, followed by heating the formed diazonium base at 30.degree.-100.degree. C. in the presence of an equimolar or more of hydrochloric acid to substitute the amino group by the chlorine atom. Further, 2-amino-5-methylthiazole and sodium nitrite are caused to react in the presence of hydrochloric acid, followed by heating the formed diazonium base at 30.degree.-100.degree. C. in the presence of an equimolar or over of hydrochloric acid to give 2-chloro-5-methylthiazole. Then, the resultant 2-chloro-5-methylthiazole is caused to react with a chlorinating agent to give 2-chloro-5-chloro-methylthiazole.